Search - tctmd.com

Displaying 1 - 20 of 156

Sort: Relevancy | Date

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

News Daily News

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

February 06, 2026

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

News Daily News

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

February 02, 2026

JACC Debuts Data Digest on CV Health in the United States

News Daily News

JACC Debuts Data Digest on CV Health in the United States

January 12, 2026

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

Year in Review: Evidence Around AI in Cardiology Grows

News Daily News

Year in Review: Evidence Around AI in Cardiology Grows

December 23, 2025

What’s Going to Be Hot at AHA 2025?

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

European Experts Provide Advice on Managing CV Effects of COVID-19

News Daily News

European Experts Provide Advice on Managing CV Effects of COVID-19

September 19, 2025

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

July 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

July 2025 Dispatch for the CV Team

July 24, 2025

Some Ups, Some Downs in Proposed CMS Reimbursement for 2026, Cardiologists Say

News Daily News

Some Ups, Some Downs in Proposed CMS Reimbursement for 2026, Cardiologists Say

July 22, 2025

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

News Daily News

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

May 09, 2025

TCTMD’s Top 10 Most Popular Stories for April 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2025

April 30, 2025

What’s Going to Be Hot at ACC 2025?

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

March 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

March 2025 Dispatch for the CV Team

March 21, 2025

Sotagliflozin Reduces Ischemic Risk in SCORED Analysis

News Daily News

Sotagliflozin Reduces Ischemic Risk in SCORED Analysis

Yael L. Maxwell

February 25, 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

News Conference News THT 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

February 12, 2025

Impact of Sitagliptin on Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction in Type 2 Diabetes Patients: A Retrospective Cohort Study

Presentation THT 2025

Impact of Sitagliptin on Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction in Type 2 Diabetes Patients: A Retrospective Cohort Study

Presenter: Thitiphan Srikulmontri

February 12, 2025

Presentation THT Abstracts 2025

Impact of Sitagliptin on Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction in Type 2 Diabetes Patients: A Retrospective Cohort Study

Presenter: Thitiphan Srikulmontri

February 11, 2025

Transplant Recipients on Medicaid More Likely to Develop Allograft Vasculopathy

News Conference News STS 2025

Transplant Recipients on Medicaid More Likely to Develop Allograft Vasculopathy

Yael L. Maxwell

January 30, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.